Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramy Ibrahim

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|January 21, 2006
Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 miceJiahua Qian, Yujun Dong, Yuk-Ying S Pang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2024
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?Anna Maria Di Giacomo, Michael Lahn, Alexander Mm Eggermont, et al.
Journal of the National Cancer Institute|September 10, 2010
Improved endpoints for cancer immunotherapy trialsAxel Hoos, Alexander M M Eggermont, Sylvia Janetzki, et al.
Endoscopic Ultrasound|April 27, 2021
Practical approach to linear EUS examination of the liverHussein Hassan Okasha, Mahmoud Farouk, Ramy Ibrahim El Hendawy, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Immunotherapy for brain metastases and primary brain tumorsAnna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2021
Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!Michele Maio, Christian Blank, Andrea Necchi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2025
Approaches to overcome the current treatment plateau in immunotherapyAnna Maria Di Giacomo, Renzo Canetta, John Connolly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2020
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 EraMichele Maio, Omid Hamid, James Larkin, et al.
Cancer Immunity|October 21, 2010
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trialsJedd D Wolchok, Jeffrey S Weber, Omid Hamid, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2025
Perspectives on the role of "-Omics" in predicting response to immunotherapyAnna Maria Di Giacomo, Sumit Subudhi, Wim Vos, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|January 21, 2006
Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV16 E2 using a chimeric VLP in HLA-A2 miceJiahua Qian, Yujun Dong, Yuk-Ying S Pang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2024
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?Anna Maria Di Giacomo, Michael Lahn, Alexander Mm Eggermont, et al.
Journal of the National Cancer Institute|September 10, 2010
Improved endpoints for cancer immunotherapy trialsAxel Hoos, Alexander M M Eggermont, Sylvia Janetzki, et al.
Endoscopic Ultrasound|April 27, 2021
Practical approach to linear EUS examination of the liverHussein Hassan Okasha, Mahmoud Farouk, Ramy Ibrahim El Hendawy, et al.
European Journal of Cancer (Oxford, England : 1990)|December 15, 2022
Immunotherapy for brain metastases and primary brain tumorsAnna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 2021
Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!Michele Maio, Christian Blank, Andrea Necchi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2025
Approaches to overcome the current treatment plateau in immunotherapyAnna Maria Di Giacomo, Renzo Canetta, John Connolly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2020
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 EraMichele Maio, Omid Hamid, James Larkin, et al.
Cancer Immunity|October 21, 2010
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trialsJedd D Wolchok, Jeffrey S Weber, Omid Hamid, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2025
Perspectives on the role of "-Omics" in predicting response to immunotherapyAnna Maria Di Giacomo, Sumit Subudhi, Wim Vos, et al.
Pageof 5